Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

L. Sellner; J. Schetelig; L. Koster; G. Choi; D. Blaise; D. Beelen; F.C. Schianca; J. Passweg; U. Schanz; E. Gyan; F. Sora; N. Kroger; G.G. Wulf; G. Van Gorkom; J. Mayer; C. Orvain; J.H. Bourhis; P. Jindra; V. Potter; F. Zallio; E. Vandenberghe; S. Robinson; P.J. Hayden; I. Yakoub-Agha; S. Montoto; P. Dreger; European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties

doi:10.1038/s41409-020-0946-x

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

L. Sellner^*
, J. Schetelig
, L. Koster
, G. Choi
, D. Blaise
, D. Beelen
, F.C. Schianca
, J. Passweg
, U. Schanz
, E. Gyan
, F. Sora
, N. Kroger
, G.G. Wulf
, G. Van Gorkom
, J. Mayer
, C. Orvain
, J.H. Bourhis
, P. Jindra
, V. Potter
, F. Zallio

E. Vandenberghe, S. Robinson, P.J. Hayden, I. Yakoub-Agha, S. Montoto, P. Dreger, European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	2335-2338
Number of pages	4
Journal	Bone Marrow Transplantation
Volume	55
Issue number	12
DOIs	https://doi.org/10.1038/s41409-020-0946-x
Publication status	Published - 1 Dec 2020

Keywords

inhibition
outcomes
rituximab
trial
TRIAL
INHIBITION
RITUXIMAB
OUTCOMES

Access to Document

10.1038/s41409-020-0946-xLicence: CC BY

1 Erratum / corrigendum

Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kröger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., Potter, V. & Zallio, F. & 7 others, Vandenberghe, E., Robinson, S., Hayden, P. J., Yakoub-Agha, I., Montoto, S., Dreger, P. & European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Dec 2021, In: Bone Marrow Transplantation. 56, 12, p. 3108-3108 1 p., 3108.
Research output: Contribution to journal › Erratum / corrigendum › Academic

Open Access

Cite this

Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kroger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., Potter, V., ... European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties (2020). Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone Marrow Transplantation, 55(12), 2335-2338. https://doi.org/10.1038/s41409-020-0946-x

@article{d7c4bd2b5d094bde932d9d4d40f0eadd,

title = "Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey",

keywords = "inhibition, outcomes, rituximab, trial, TRIAL, INHIBITION, RITUXIMAB, OUTCOMES",

author = "L. Sellner and J. Schetelig and L. Koster and G. Choi and D. Blaise and D. Beelen and F.C. Schianca and J. Passweg and U. Schanz and E. Gyan and F. Sora and N. Kroger and G.G. Wulf and \{Van Gorkom\}, G. and J. Mayer and C. Orvain and J.H. Bourhis and P. Jindra and V. Potter and F. Zallio and E. Vandenberghe and S. Robinson and P.J. Hayden and I. Yakoub-Agha and S. Montoto and P. Dreger and \{European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties\}",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41409-020-0946-x",

language = "English",

volume = "55",

pages = "2335--2338",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer",

number = "12",

}

Sellner, L, Schetelig, J, Koster, L, Choi, G, Blaise, D, Beelen, D, Schianca, FC, Passweg, J, Schanz, U, Gyan, E, Sora, F, Kroger, N, Wulf, GG, Van Gorkom, G, Mayer, J, Orvain, C, Bourhis, JH, Jindra, P, Potter, V, Zallio, F, Vandenberghe, E, Robinson, S, Hayden, PJ, Yakoub-Agha, I, Montoto, S, Dreger, P & European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties 2020, 'Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey', Bone Marrow Transplantation, vol. 55, no. 12, pp. 2335-2338. https://doi.org/10.1038/s41409-020-0946-x

TY - JOUR

T1 - Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

AU - Sellner, L.

AU - Schetelig, J.

AU - Koster, L.

AU - Choi, G.

AU - Blaise, D.

AU - Beelen, D.

AU - Schianca, F.C.

AU - Passweg, J.

AU - Schanz, U.

AU - Gyan, E.

AU - Sora, F.

AU - Kroger, N.

AU - Wulf, G.G.

AU - Van Gorkom, G.

AU - Mayer, J.

AU - Orvain, C.

AU - Bourhis, J.H.

AU - Jindra, P.

AU - Potter, V.

AU - Zallio, F.

AU - Vandenberghe, E.

AU - Robinson, S.

AU - Hayden, P.J.

AU - Yakoub-Agha, I.

AU - Montoto, S.

AU - Dreger, P.

AU - European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties

PY - 2020/12/1

Y1 - 2020/12/1

KW - inhibition

KW - outcomes

KW - rituximab

KW - trial

KW - TRIAL

KW - INHIBITION

KW - RITUXIMAB

KW - OUTCOMES

U2 - 10.1038/s41409-020-0946-x

DO - 10.1038/s41409-020-0946-x

M3 - Comment/Letter to the editor

C2 - 32444863

SN - 0268-3369

VL - 55

SP - 2335

EP - 2338

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 12

ER -

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Keywords

Access to Document

Research output

Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Cite this